MM
Michael Markbreiter
Director

Michael Markbreiter insider trades: Impax Laboratories (IPXL) stock sales

Director, Impax Laboratories Last trade Aug 31, 2015 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2009
1
Company
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 31, 2015IPXL↓ Sell$1.2M
Aug 26, 2015IPXL↓ Sell$819K
May 8, 2014IPXL↓ Sell$330K
Mar 11, 2014IPXL↓ Sell$110K
Nov 16, 2012IPXL↓ Sell$132K
Jun 7, 2011IPXL↓ Sell$473K
May 20, 2010IPXL↓ Sell$377K
Mar 2, 2010IPXL↓ Sell$231K
Nov 6, 2009IPXL↓ Sell$39K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael Markbreiter's insider trades

Michael Markbreiter is a director at Impax Laboratories (IPXL). Since Nov 6, 2009, Michael has reported no open-market purchases and 9 sales worth $3.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (7 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IPXL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.